--A judge ruled in favor of Teva Pharmaceuticals Industries Ltd., and against Opiant Pharmaceuticals Inc. and Emergent Biosolutions Inc., in a patent dispute related to Narcan spray, Bloomberg Law reported Friday.

--Opiant shares fell 35% to $7.57 after hours, while Emergent was down 14% to $75. Teva rose 1.6% to $13.05

Full story: https://news.bloomberglaw.com/health-law-and-business/teva-beats-opiant-emergent-in-patent-ruling-on-narcan-spray

Write to Josh Beckerman at josh.beckerman@wsj.com